A multiple interval physical map of the pericentromeric region of human chromosome 10. 1994

A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
Department of Pathology, University of Cambridge, UK.

Five intervals in the pericentromeric region of human chromosome 10 have been defined using a panel of somatic cell hybrids carrying portions of the chromosome. The map positions of twelve markers, consisting of four genes and eight anonymous DNA segments, have been localized by assignment to one of the five intervals. Several other markers could be placed in specific intervals by genetic linkage to assigned loci. When previously published data are incorporated, the summary map of the pericentromeric region encompasses thirty-two loci in bands 10p11.2-q11.2.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009377 Multiple Endocrine Neoplasia A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively. Adenomatosis, Familial Endocrine,Endocrine Neoplasia, Multiple,Multiple Endocrine Neoplasia Syndrome,Neoplasia, Multiple Endocrine,Neoplasms, Multiple Endocrine,Adenomatosis, Multiple Endocrine,Familial Endocrine Adenomatosis,Multiple Endocrine Adenomatosis,Multiple Endocrine Adenopathy,Multiple Endocrine Neoplasia Syndromes,Multiple Endocrine Neoplasms,Adenomatoses, Familial Endocrine,Adenomatoses, Multiple Endocrine,Adenopathies, Multiple Endocrine,Adenopathy, Multiple Endocrine,Endocrine Adenomatoses, Familial,Endocrine Adenomatoses, Multiple,Endocrine Adenomatosis, Familial,Endocrine Adenomatosis, Multiple,Endocrine Adenopathies, Multiple,Endocrine Adenopathy, Multiple,Endocrine Neoplasms, Multiple,Familial Endocrine Adenomatoses,Multiple Endocrine Adenomatoses,Multiple Endocrine Adenopathies
D002503 Centromere The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. Centromeres
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002879 Chromosomes, Human, Pair 10 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 10
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006822 Hybrid Cells Any cell, other than a ZYGOTE, that contains elements (such as NUCLEI and CYTOPLASM) from two or more different cells, usually produced by artificial CELL FUSION. Somatic Cell Hybrids,Cell Hybrid, Somatic,Cell Hybrids, Somatic,Cell, Hybrid,Cells, Hybrid,Hybrid Cell,Hybrid, Somatic Cell,Hybrids, Somatic Cell,Somatic Cell Hybrid
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
November 1990, Genomics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
May 1988, Genomics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
March 1993, Genomics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
March 1995, Genomics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
December 1993, Nucleic acids research,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
August 1993, Nature genetics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
July 1995, Human genetics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
July 1992, Genomics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
June 1995, Genomics,
A Tunnacliffe, and M S Jackson, and E Gardner, and D R Love, and J K Moore, and S E Mole, and L M Mulligan, and A Graham, and G Finocchiaro, and S Orstavik
January 2005, Cytogenetic and genome research,
Copied contents to your clipboard!